Vitalipid N Emulsion
NDC Package 65219-337-62

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vitalipid N (vitamin a palmitate, ergocalciferol, .alpha.-tocopherol, dl-, phytonadione) emulsions is classified as a

administered via intravenous route. This formulation utilizes a emulsion delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 65219-337.

Identification & Billing

NDC Package Code
65219-337-62
Package Description
10 AMPULE in 1 CARTON / 10 mL in 1 AMPULE (65219-337-10)
Product Code
65219-337
11-Digit Billing Format
65219033762

Clinical Specifications

Proprietary Name
Vitalipid N
Non-Proprietary Name
Vitamin A Palmitate, Ergocalciferol, .alpha.-tocopherol, Dl-, Phytonadione
Substance Name
.alpha.-tocopherol, Dl-; Ergocalciferol; Phytonadione; Vitamin A Palmitate
Dosage Form
Emulsion - A dosage form consisting of a two-phase system comprised of at least two immiscible liquids1, one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. (Note: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment.)
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Fresenius Kabi Usa, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE -
Start Marketing Date
08-18-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65219-337-62 identifies a specific commercial package of 10 ampule in 1 carton / 10 ml in 1 ampule (65219-337-10) of Vitalipid N, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This emulsion is formulated for intravenous use and contains .alpha.-tocopherol, dl-; ergocalciferol; phytonadione; vitamin a palmitate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on August 18, 2023. The current certification is valid through December 31, 2026.

How is this Fresenius Kabi Usa, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65219033762. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65219-337-62
11-Digit CMS (5-4-2)
65219-0337-62

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.